BRIAN MELTON: Open Payments
NPI 1093251480 · DRY RIDGE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,269 in 139 payments from 30 companies in 2025. Trend: 2023 $1,878 · 2024 $2,270 · 2025 $2,269
Food & beverage: $2,269
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $327 |
| GlaxoSmithKline, LLC. | 19 | $247 |
| Novo Nordisk Inc | 12 | $232 |
| PFIZER INC. | 14 | $195 |
| Otsuka America Pharmaceutical, Inc. | 12 | $167 |
| Phathom Pharmaceuticals, Inc. | 6 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $97 |
| Lilly USA, LLC | 6 | $95 |
| Dexcom, Inc. | 3 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
Products named: REXULTI, TRELEGY ELLIPTA, VRAYLAR, Wegovy, VOQUEZNA, NURTEC ODT, Ozempic, CAPLYTA.
Industry payments across KY — which companies pay providers there.
